Apogee Therapeutics, Inc.
APGE
Hisse Senetlerindeki Sıralama
#2347
Apogee Therapeutics, Inc. is a biotechnology firm, operating via its... Apogee Therapeutics, Inc. is a biotechnology firm, operating via its subsidiary, dedicated to advancing biologic treatments for conditions such as atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and a range of other inflammatory and immunological disorders. Its primary focus includes APG777, a subcutaneous (SQ) monoclonal antibody (mAb) engineered for an extended half-life to treat AD, and APG808, a similarly formulated SQ extended half-life mAb targeting COPD. Furthermore, its earlier-stage pipeline features APG990, another SQ extended half-life mAb designed for AD, and APG222, comprising extended half-life subcutaneous antibodies also aimed at AD. Established in 2022, the company maintains its headquarters in Waltham, Massachusetts.
Hisse Fiyatı
$135.07
Son senkronizasyon: 2026-09-04
Piyasa Değeri
$8.36B
Değişim (1 gün)
0.00%
Değişim (1 yıl)
137.21%
Ülke
US
Ticaret Apogee Therapeutics, Inc. (APGE)
Kategori
Healthcare
Apogee Therapeutics, Inc. (APGE) için temettü verimi geçmişi
Apogee Therapeutics, Inc. (hisse sembolü: APGE) temettü verimi (TTM) 2023-12-31 itibariyle: 0.00%
Son 5 yılın ortalama temettü verimi: 0.00%
Son 5 yılın ortalama temettü verimi: 0.00%
Apogee Therapeutics, Inc. (APGE) için 2022 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
| Yıl | Temettü Verimi | Değiştir |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
Benzer şirketler veya rakiplerin temettü verimi (TTM)
| Şirket | Temettü Verimi | Ülke |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.17% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
